Plasma interleukin-6 and executive function in crack cocaine-dependent women

Neuroscience Letters

Volumn 628, Issue , 2016, Pages 85-90

  Levandowski, Mateus Luz ^a   Hess, Adriana Raquel Binsfeld ^b,c   Grassi Oliveira, Rodrigo ^a   de Almeida, Rosa Maria Martins ^b  

^a PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c UNIVERSIDADE DO VALE DO RIO DOS SINOS   (Brazil)

Author keywords

Biomarkers; Cocaine; Cognitive function; Cytokine; Disorder; Inflammation; Substance use

Indexed keywords

COCAINE; INTERLEUKIN 6;

ADULT; ARTICLE; CLINICAL ARTICLE; COCAINE DEPENDENCE; CONTROLLED STUDY; CYTOMETRY; EDUCATION; EXECUTIVE FUNCTION; FEMALE; HUMAN; INTELLIGENCE QUOTIENT; LINEAR REGRESSION ANALYSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; WISCONSIN CARD SORTING TEST; BLOOD; COMPLICATION; INFLAMMATION; PSYCHOLOGY;

ADULT; COCAINE-RELATED DISORDERS; CRACK COCAINE; EXECUTIVE FUNCTION; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-6;

EID: 84975474136     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2016.06.023     Document Type: Article

References (69)

1. Ahmed S.H., Lutjens R., van der Stap L.D., Lekic D., Romano-Spica V., Morales M., Sanna P.P. Gene expression evidence for remodeling of lateral hypothalamic circuitry in cocaine addiction. Proc. Natl. Acad. Sci. U. S. A. 2005, 102(32):11533-11538. 10.1073/pnas.0504438102.
2. Araos P., Pedraz M., Serrano A., Lucena M., Barrios V., Garcia-Marchena N., Rodriguez de Fonseca F. Plasma profile of pro-inflammatory cytokines and chemokines in cocaine users under outpatient treatment: influence of cocaine symptom severity and psychiatric co-morbidity. Addict. Biol. 2015, 20(4):756-772. 10.1111/adb.12156.
3. Axelrod B.N. Validity of the Wechsler abbreviated scale of intelligence and other very short forms of estimating intellectual functioning. Assessment 2002, 9(1):17-23.
4. Bastos F.I., Bertoni N. Pesquisa Nacional Sobre O Uso De Crack: Quem são Os Usuários De Crack e/ou Similares No Brasil? Quantos são Nas Capitais Brasileiras? 2014, ICICT/FIOCRUZ, Rio de Janeiro.
5. Best J.R., Miller P.H. A developmental perspective on executive function. Child Dev. 2010, 81(6):1641-1660. 10.1111/j.1467-8624.2010.01499.x.
6. Campbell I.L., Stalder A.K., Chiang C.S., Bellinger R., Heyser C.J., Steffensen S., Siggins G.R. Transgenic models to assess the pathogenic actions of cytokines in the central nervous system. Mol. Psychiatry 1997, 2(2):125-129.
7. Cheng G.L., Zeng H., Leung M.K., Zhang H.J., Lau B.W., Liu Y.P., Lee T.M. Heroin abuse accelerates biological aging: a novel insight from telomerase and brain imaging interaction. Transl. Psychiatry 2013, 3:e260. 10.1038/tp.2013.36.
8. Ciaramella A., Bizzoni F., Salani F., Vanni D., Spalletta G., Sanarico N., Bossu P. Increased pro-inflammatory response by dendritic cells from patients with Alzheimer's disease. J. Alzheimers Dis. 2010, 19(2):559-572. 10.3233/JAD-2010-1257.
9. Clark K.H., Wiley C.A., Bradberry C.W. Psychostimulant abuse and neuroinflammation: emerging evidence of their interconnection. Neurotox. Res. 2013, 23(2):174-188. 10.1007/s12640-012-9334-7.
10. Cunha P.J., Bechara A., de Andrade A.G., Nicastri S. Decision-making deficits linked to real-life social dysfunction in crack cocaine-dependent individuals. Am. J. Addict. 2011, 20(1):78-86. 10.1111/j.1521-0391.2010.00097.x.
11. Dalley J.W., Everitt B.J., Robbins T.W. Impulsivity, compulsivity, and top-down cognitive control. Neuron 2011, 69(4):680-694. 10.1016/j.neuron.2011.01.020.
12. Dantzer R., O'Connor J.C., Freund G.G., Johnson R.W., Kelley K.W. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 2008, 9(1):46-56. 10.1038/nrn2297.
13. Del-Ben C.M., Vilela J.A.A., Crippa J.A.S., Hallaka J.E.C., Labate C.M., Zuardi A.W. Reliability of the structured clinical interview for DSM-IV e clinical version translated into Portuguese. Braz. J. Psychiatry 2001, 23:4.
14. Dowlati Y., Herrmann N., Swardfager W., Liu H., Sham L., Reim E.K., Lanctot K.L. A meta-analysis of cytokines in major depression. Biol. Psychiatry 2010, 67(5):446-457. 10.1016/j.biopsych.2009.09.033.
15. Elenkov I.J. Glucocorticoids and the Th1/Th2 balance. Ann. N. Y. Acad. Sci. 2004, 1024:138-146. 10.1196/annals.1321.010.
16. Folstein M.F., Folstein S.E., McHugh P.R. Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 1975, 12(3):189-198.
17. Fox H.C., D'Sa C., Kimmerling A., Siedlarz K.M., Tuit K.L., Stowe R., Sinha R. Immune system inflammation in cocaine dependent individuals: implications for medications development. Hum. Psychopharmacol. 2012, 27(2):156-166. 10.1002/hup.1251.
18. Galimberti D., Venturelli E., Fenoglio C., Guidi I., Villa C., Bergamaschini L., Scarpini E. Intrathecal levels of IL-6, IL-11 and LIF in Alzheimer's disease and frontotemporal lobar degeneration. J. Neurol. 2008, 255(4):539-544. 10.1007/s00415-008-0737-6.
19. Ghosh A., Birngruber T., Sattler W., Kroath T., Ratzer M., Sinner F., Pieber T.R. Assessment of blood-brain barrier function and the neuroinflammatory response in the rat brain by using cerebral open flow microperfusion (cOFM). PLoS One 2014, 9(5):e98143. 10.1371/journal.pone.0098143.
20. Gianaros P.J., Marsland A.L., Sheu L.K., Erickson K.I., Verstynen T.D. Inflammatory pathways link socioeconomic inequalities to white matter architecture. Cereb. Cortex 2013, 23(9):2058-2071. 10.1093/cercor/bhs191.
21. Gilbert S.J., Burgess P.W. Executive function. Curr. Biol. 2008, 18(3):R110-R114. 10.1016/j.cub.2007.12.014.
22. Goldstein R.Z., Leskovjan A.C., Hoff A.L., Hitzemann R., Bashan F., Khalsa S.S., Volkow N.D. Severity of neuropsychological impairment in cocaine and alcohol addiction: association with metabolism in the prefrontal cortex. Neuropsychologia 2004, 42(11):1447-1458. 10.1016/j.neuropsychologia.2004.04.002.
23. Gomes-Oliveira M.H., Gorenstein C., Lotufo Neto F., Andrade L.H., Wang Y.P. Validation of the Brazilian Portuguese version of the beck depression inventory-II in a community sample. Rev. Bras. Psiquiatr. 2012, 34(4):389-394.
24. Gorenstein C., Andrade L. Validation of a portuguese version of the beck depression inventory and the state-trait anxiety inventory in brazilian subjects. Braz. J. Med. Biol. Res. 1996, 29(4):453-457.
25. Greve K.W., Stickle T.R., Love J.M., Bianchini K.J., Stanford M.S. Latent structure of the Wisconsin Card Sorting Test: a confirmatory factor analytic study. Arch. Clin. Neuropsychol. 2005, 20(3):355-364. 10.1016/j.acn.2004.09.004.
26. Gruol D.L. IL-6 regulation of synaptic function in the CNS. Neuropharmacology 2015, 96(Pt A):42-54. 10.1016/j.neuropharm.2014.10.023.
27. Hamdani N., Daban-Huard C., Lajnef M., Gadel R., Le Corvoisier P., Delavest M., Leboyer M. Cognitive deterioration among bipolar disorder patients infected by Toxoplasma gondii is correlated to interleukin 6 levels. J. Affect Disord. 2015, 179:161-166. 10.1016/j.jad.2015.03.038.
28. Jentsch J.D., Olausson P., De La Garza R., Taylor J.R. Impairments of reversal learning and response perseveration after repeated, intermittent cocaine administrations to monkeys. Neuropsychopharmacology 2002, 26(2):183-190. 10.1016/S0893-133X(01)00355-4.
29. Kampman K.M., Volpicelli J.R., McGinnis D.E., Alterman A.I., Weinrieb R.M., D'Angelo L., Epperson L.E. Reliability and validity of the cocaine selective severity assessment. Addict. Behav. 1998, 23(4):449-461.
30. Kluwe-Schiavon B., Tractenberg S.G., Sanvicente-Vieira B., Rosa C.S.O., Arteche A.X., Pezzi J.C., Grassi-Oliveira R. Psychometric properties of cocaine selective severity assessment (CSSA) in crack users. J. Bras. Psiquiatr. 2015, 64(2):115-121.
31. Kohman R.A., Rhodes J.S. Neurogenesis, inflammation and behavior. Brain Behav. Immun. 2013, 27(1):22-32. 10.1016/j.bbi.2012.09.003.
32. Kousik S.M., Napier T.C., Carvey P.M. The effects of psychostimulant drugs on blood brain barrier function and neuroinflammation. Front. Pharmacol. 2012, 3:121. 10.3389/fphar.2012.00121.
33. Kozora E., Laudenslager M., Lemieux A., West S.G. Inflammatory and hormonal measures predict neuropsychological functioning in systemic lupus erythematosus and rheumatoid arthritis patients. J. Int. Neuropsychol. Soc. 2001, 7(6):745-754.
34. Kronfol Z., Remick D.G. Cytokines and the brain: implications for clinical psychiatry. Am. J. Psychiatry 2000, 157(5):683-694.
35. Kubera M., Filip M., Budziszewska B., Basta-Kaim A., Wydra K., Leskiewicz M., Lason W. Immunosuppression induced by a conditioned stimulus associated with cocaine self-administration. J. Pharmacol. Sci. 2008, 107(4):361-369.
36. Levandowski M.L., Viola T.W., Tractenberg S.G., Teixeira A.L., Brietzke E., Bauer M.E., Grassi-Oliveira R. Adipokines during early abstinence of crack cocaine in dependent women reporting childhood maltreatment. Psychiatry Res. 2013, 210(2):536-540. 10.1016/j.psychres.2013.07.007.
37. Levandowski M.L., Viola T.W., Wearick-Silva L.E., Wieck A., Tractenberg S.G., Brietzke E., Grassi-Oliveira R. Early life stress and tumor necrosis factor superfamily in crack cocaine withdrawal. J. Psychiatr. Res. 2014, 53:180-186. 10.1016/j.jpsychires.2014.02.017.
38. Marsland A.L., Gianaros P.J., Kuan D.C., Sheu L.K., Krajina K., Manuck S.B. Brain morphology links systemic inflammation to cognitive function in midlife adults. Brain Behav. Immun. 2015, 48:195-204. 10.1016/j.bbi.2015.03.015.
39. Miller A.H., Haroon E., Raison C.L., Felger J.C. Cytokine targets in the brain: impact on neurotransmitters and neurocircuits. Depress. Anxiety 2013, 30(4):297-306. 10.1002/da.22084.
40. Monchi O., Petrides M., Petre V., Worsley K., Dagher A. Wisconsin Card Sorting revisited: distinct neural circuits participating in different stages of the task identified by event-related functional magnetic resonance imaging. J. Neurosci. 2001, 21(19):7733-7741.
41. Moreira F.P., Medeiros J.R., Lhullier A.C., Souza L.D., Jansen K., Portela L.V., Oses J.P. Cocaine abuse and effects in the serum levels of cytokines IL-6 and IL-10. Drug Alcohol Depend. 2016, 158:181-185. 10.1016/j.drugalcdep.2015.11.024.
42. Nyhus E., Barcelo F. The Wisconsin Card Sorting Test and the cognitive assessment of prefrontal executive functions: a critical update. Brain Cogn. 2009, 71(3):437-451. 10.1016/j.bandc.2009.03.005.
43. Perrone P.A. The therapeutic community for recuperation from addiction to alcohol and other drugs in Brasil: in line with or running counter to psychiatric reform?. Cien. Saude Colet. 2014, 19(2):569-580.
44. Potvin S., Stavro K., Rizkallah E., Pelletier J. Cocaine and cognition: a systematic quantitative review. J. Addict. Med. 2014, 8(5):368-376. 10.1097/ADM.0000000000000066.
45. Potvin S., Stip E., Sepehry A.A., Gendron A., Bah R., Kouassi E. Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review. Biol. Psychiatry 2008, 63(8):801-808. 10.1016/j.biopsych.2007.09.024.
46. Quinones-Jenab V. Why are women from Venus and men from Mars when they abuse cocaine?. Brain Res. 2006, 1126(1):200-203. 10.1016/j.brainres.2006.08.109.
47. Rafnsson S.B., Deary I.J., Smith F.B., Whiteman M.C., Rumley A., Lowe G.D., Fowkes F.G. Cognitive decline and markers of inflammation and hemostasis: the Edinburgh artery study. J. Am. Geriatr. Soc. 2007, 55(5):700-707. 10.1111/j.1532-5415.2007.01158.x.
48. Reece A.S. Evidence of accelerated ageing in clinical drug addiction from immune, hepatic and metabolic biomarkers. Immun. Ageing 2007, 4:6. 10.1186/1742-4933-4-6.
49. Reece A.S. Chronic immune stimulation as a contributing cause of chronic disease in opiate addiction including multi-system ageing. Med. Hypotheses 2010, 75(6):613-619. 10.1016/j.mehy.2010.07.047.
50. Reichenberg A., Yirmiya R., Schuld A., Kraus T., Haack M., Morag A., Pollmacher T. Cytokine-associated emotional and cognitive disturbances in humans. Arch. Gen. Psychiatry 2001, 58(5):445-452.
51. Schram M.T., Euser S.M., de Craen A.J., Witteman J.C., Frolich M., Hofman A., Westendorp R.G. Systemic markers of inflammation and cognitive decline in old age. J. Am. Geriatr. Soc. 2007, 55(5):708-716. 10.1111/j.1532-5415.2007.01159.x.
52. Sharma H.S., Muresanu D., Sharma A., Patnaik R. Cocaine-induced breakdown of the blood-brain barrier and neurotoxicity. Int. Rev. Neurobiol. 2009, 88:297-334. 10.1016/S0074-7742(09)88011-2.
53. Spooren A., Kolmus K., Laureys G., Clinckers R., De Keyser J., Haegeman G., Gerlo S. Interleukin-6, a mental cytokine. Brain Res. Rev. 2011, 67(1-2):157-183. 10.1016/j.brainresrev.2011.01.002.
54. Spronk D.B., van Wel J.H., Ramaekers J.G., Verkes R.J. Characterizing the cognitive effects of cocaine: a comprehensive review. Neurosci. Biobehav. Rev. 2013, 37(8):1838-1859. 10.1016/j.neubiorev.2013.07.003.
55. Tancredi V., D'Antuono M., Cafe C., Giovedi S., Bue M.C., D'Arcangelo G., Benfenati F. The inhibitory effects of interleukin-6 on synaptic plasticity in the rat hippocampus are associated with an inhibition of mitogen-activated protein kinase ERK. J. Neurochem. 2000, 75(2):634-643.
56. Tien A.Y., Spevack T.V., Jones D.W., Pearlson G.D., Schlaepfer T.E., Strauss M.E. Computerized wisconsin card sorting test: comparison with manual administration. Kaohsiung J. Med. Sci. 1996, 12(8):479-485.
57. Tirapu-Ustarroz J., Garcia-Molina A., Luna-Lario P., Roig-Rovira T., Pelegrin-Valero C. Models of executive control and functions (I). Rev. Neurol. 2008, 46(11):684-692.
58. Trapero I., Cauli O. Interleukin 6 and cognitive dysfunction. Metab. Brain Dis. 2014, 29(3):593-608. 10.1007/s11011-014-9551-2.
59. Vallieres L., Campbell I.L., Gage F.H., Sawchenko P.E. Reduced hippocampal neurogenesis in adult transgenic mice with chronic astrocytic production of interleukin-6. J. Neurosci. 2002, 22(2):486-492.
60. Verdejo-Garcia A., Perez-Garcia M. Profile of executive deficits in cocaine and heroin polysubstance users: common and differential effects on separate executive components. Psychopharmacology (Berl) 2007, 190(4):517-530. 10.1007/s00213-006-0632-8.
61. Verstynen T.D., Weinstein A., Erickson K.I., Sheu L.K., Marsland A.L., Gianaros P.J. Competing physiological pathways link individual differences in weight and abdominal adiposity to white matter microstructure. Neuroimage 2013, 79:129-137. 10.1016/j.neuroimage.2013.04.075.
62. Viola T.W., Tractenberg S.G., Kluwe-Schiavon B., Levandowski M.L., Sanvicente-Vieira B., Wearick-Silva L.E., Grassi-Oliveira R. Brain-Derived neurotrophic factor and delayed verbal recall in crack cocaine dependents. Eur. Addict. Res. 2015, 21(5):273-278. 10.1159/000430436.
63. Viola T.W., Tractenberg S.G., Pezzi J.C., Kristensen C.H., Grassi-Oliveira R. Childhood physical neglect associated with executive functions impairments in crack cocaine-dependent women. Drug Alcohol Depend. 2013, 132(1-2):271-276. 10.1016/j.drugalcdep.2013.02.014.
64. Volkow N.D., Fowler J.S., Wang G.J., Baler R., Telang F. Imaging dopamine's role in drug abuse and addiction. Neuropharmacology 2009, 56(Suppl. 1):3-8. 10.1016/j.neuropharm.2008.05.022.
65. Volkow N.D., Koob G., Baler R. Biomarkers in substance use disorders. ACS Chem. Neurosci. 2015, 6(4):522-525. 10.1021/acschemneuro.5b00067.
66. Wang J., Dunn A.J. Mouse interleukin-6 stimulates the HPA axis and increases brain tryptophan and serotonin metabolism. Neurochem. Int. 1998, 33(2):143-154.
67. Woicik P.A., Urban C., Alia-Klein N., Henry A., Maloney T., Telang F., Goldstein R.Z. A pattern of perseveration in cocaine addiction may reveal neurocognitive processes implicit in the Wisconsin Card Sorting Test. Neuropsychologia 2011, 49(7):1660-1669. 10.1016/j.neuropsychologia.2011.02.037.
68. Yamada K., Nabeshima T. Pro- and anti-addictive neurotrophic factors and cytokines in psychostimulant addiction: mini review. Ann. N. Y. Acad. Sci. 2004, 1025:198-204. 10.1196/annals.1316.025.
69. Yirmiya R., Goshen I. Immune modulation of learning, memory, neural plasticity and neurogenesis. Brain Behav. Immun. 2011, 25(2):181-213. 10.1016/j.bbi.2010.10.015.